Home › Squamous Cell Carcinoma ng Ulo at Leeg › Virginia › Arlington

Pag-aaral pangklinika para sa Squamous Cell Carcinoma ng Ulo at Leeg sa Arlington, VA

26 pag-aaral para sa Squamous Cell Carcinoma ng Ulo at Leeg ang naghahanap ng mga kalahok sa mga site sa loob at paligid ng Arlington (sa loob ng humigit-kumulang 30 milya). Buksan ang pag-aaral upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

A Phase 1, First-in-Human (FIH), Open-Label, Dose-Escalation and Dose Expansion Study of the Peptide Drug Conjugate (PDC), TS-104, as a Monotherapy in Subjects With Select Advanced Solid Tumors

Nagre-recruitPhase 1

Site 04, Fairfax · 11 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Set 30, 2026 · NCT07814248

A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors

Nagre-recruitPhase 1

ALX Center 2, Fairfax · 11 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Set 30, 2026 · NCT07085091

A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer

Nagre-recruitPhase 3

Virginia Cancer Specialists, Fairfax · 11 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT07276399

A Study of Amivantamab Alone or in Addition to Other Treatment Agents in Participants With Head and Neck Cancer

Nagre-recruitPhase 1/2

Virginia Cancer Specialists, Fairfax · 11 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT06385080

BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study

Nagre-recruitPhase 2

Inova Fairfax Hospital, Falls Church · 4 mi ang layo
Inova Schar Cancer Institute, Fairfax · 11 mi ang layo
Inova Fair Oaks Hospital, Fairfax · 11 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT05136196

Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors

Nagre-recruitPhase 1

Virginia Cancer Specialists, Fairfax · 11 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Set 21, 2026 · NCT05983432

A Study of ASP388B Given by Itself and With Standard Therapies in Participants With Solid Tumors

Nagre-recruitPhase 1/2

NEXT Virginia, Fairfax · 11 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Set 18, 2026 · NCT07730021

A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations

Nagre-recruitPhase 1/2

NEXT Oncology, Fairfax · 11 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Set 17, 2026 · NCT07109726

A Study to See if Giving Fianlimab and Cemiplimab Together is Better Than Cemiplimab Alone at Treating Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Nagre-recruitPhase 2

Inova Schar Cancer Institute, Fairfax · 11 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 21, 2026 · NCT06769698

A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors

Nagre-recruitPhase 1/2

Research Site, Fairfax · 11 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 19, 2026 · NCT07115043

A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors

Nagre-recruitPhase 1

Normunity Investigational Site, Fairfax · 11 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 18, 2026 · NCT07182149

A Study of DM005 in Patients With Advanced Solid Tumors

Nagre-recruitPhase 1/2

NEXT Oncology Virginia, Fairfax · 11 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 7, 2026 · NCT06515990

A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)

Nagre-recruitPhase 1/2

Virginia Cancer Specialists, Fairfax · 11 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 5, 2026 · NCT06330064

A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors

Nagre-recruitPhase 1

NEXT Virginia, Fairfax · 11 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Hul 22, 2026 · NCT05208762

First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors

Nagre-recruitPhase 1/2

USO-Virginia Cancer Specialists, PC, Fairfax · 11 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Hul 7, 2026 · NCT05768139

A Study of Sigvotatug Vedotin in Advanced Solid Tumors

Nagre-recruitPhase 1

Virginia Cancer Specialists, Fairfax · 11 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Hul 6, 2026 · NCT04389632

A Study to Investigate ALE.P02 as Monotherapy in Adult Patients With Selected CLDN1+ Solid Tumors

Nagre-recruitPhase 1/2

NEXT Oncology Virginia, Fairfax · 11 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Hun 29, 2026 · NCT06747585

Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors

Nagre-recruitPhase 1/2

NEXT, Fairfax · 11 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Hun 23, 2026 · NCT06993844

Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan

Nagre-recruitPhase 1

Virginia Cancer Specialists - Fairfax /ID# 232592, Fairfax · 11 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Hun 23, 2026 · NCT05005403

A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types

Nagre-recruitPhase 1

NEXT Texas LLC - Virginia, Fairfax · 11 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Hun 18, 2026 · NCT07503808

A Study of DB-1310 in Advanced/Metastatic Solid Tumors

Nagre-recruitPhase 1/2

NEXT Virginia, Fairfax · 11 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Abr 6, 2026 · NCT05785741

Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors

Nagre-recruitPhase 1/2

NEXT Virginia, Fairfax · 11 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Peb 18, 2026 · NCT07030257

A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas

Nagre-recruitPhase 1

Dren Investigational Site, Fairfax · 11 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Ene 7, 2026 · NCT06999187

Study to Evaluate LB-LR1109, Administered Alone for the Treatment of Solid Tumor and in Combination With Atezolizumab for the Treatment of NSCLC

Nagre-recruitPhase 1

NEXT Oncology, Fairfax · 11 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Nob 24, 2025 · NCT06332755

A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors

Nagre-recruitPhase 1/2

Research Site 102, Fairfax · 11 mi ang layo
Research Site 112, Fairfax · 11 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Nob 21, 2025 · NCT05914116

A Clinical Study of Intratumoral MVR-T3011 (T3011) Given as a Single Agent and in Combination With Intravenous Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors

Nagre-recruitPhase 1/2

Virginia Cancer Specialists, Fairfax · 11 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 8, 2025 · NCT04370587

Pag-aaral para sa Squamous Cell Carcinoma ng Ulo at Leeg sa ibang lungsod

Iba pang pag-aaral sa Arlington

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.